Delivering a new dimension in healthcare About genedrive plc About Us The genedrive plc Team How to Find Us Careers at genedrive plc Investor Information Investors Overview Company Profile Company Directors Shareholder Information Share Price Information RNS Announcements Company Reports Constitutional Documents Corporate Governance Advisors Corporate News News Press Releases Epistem Novel Therapies Novel Therapies Pipeline Genedrive® Diagnostics Genedrive® Overview Product Overview MTB/RIF Overview Distributors News Epistem Pharmacogenomics Overview Assessing Limited Quantities of RNA Plucked Hair Analysis Laser Capture Microdissection Gene Expression Analysis DNA Genotyping Analysis Liquid Biopsies Genedrive® Diagnostics Preclinical Contract Research Services About Pharmacogenomics Epistem Contract Research Overview Oncology GI Toxicity and Mucositis Biodefense Inflammation Skin Wound Healing Plucked Hair Biomarker Platform Analytical Services News & Events About Contract Research Contact Us Welcome to genedrive plc Epistem Holdings plc is renamed genedrive plc genedrive plc is developing and commercialising a low cost, rapid, versatile point-of-need diagnostics platform for the diagnosis of infectious diseases, patient stratification (genotyping), pathogen detection and other indications. The Genedrive® MTB/RIF test has been launched in India and a Genedrive® HCV test has been successfully assessed by the Institut Pasteur, Paris. Headquartered in Manchester UK (with facilities in the US) and founded on ground-breaking research in epithelial stem cell biology, genedrive plc has evolved into a dynamic and successful enterprise enabling advances in medicine through the provision of innovative services and pioneering products. For over fifteen years, genedrive plc's services divisions trading as Epistem have offered a personalised service to customers worldwide, from virtual start-ups to established biotechnology enterprises, global pharmaceutical and personal care companies. Company Overview [+] Genedrive® System A pioneering Point of Care/Need molecular diagnostic platform providing low cost, accurate, next generation genotyping and sequence analysis in 45-75 minutes depending on the assay. Epistem Contract Research Committed to providing reliable, innovative and transferable pre-clinical models and services to support decision making throughout the drug discovery and development pipeline. Epistem Pharmacogenomics Specialists in gene expression and DNA genotyping, providing GCLP accredited services to drug development and diagnostic programs. Shares News Company Reports Careers Quality Share Price 82.5p 0p change Last Updated: Sat Jul 30 13:58 (15 min delay share price) Epistem lines up £2.5m cornerstone investor Tuesday June 07, 2016 Manchester-headquartered biotechnology company Epistem has lined up a £2.5m cornerstone investor to Upcoming Webinar to Examine Pre-Clinical Models of Intestinal Toxicity Tuesday May 24, 2016 /EINPresswire.com/ -- TORONTO, ON--(Marketwired - May 24, 2016) - On Friday, June 10, 2016, at 10am EDT (3pm BST/UK), Xtalks will host a complimentary webinar featuring Cath Booth, Co-Founder and Managing Director of Contract Research Services at Epistem as the keynote speaker. Epistem's diagnostic test scores well in hepatitis trial Tuesday May 03, 2016 Epistem Holdings Plc’s (LON:EHP) rapid diagnostic system Genedrive has performed well in Epistem funding from US Department of Defense Monday March 21, 2016 StockMarketWire.com - The US Department of Defense has awarded Epistem $2.9m in funding for the next phase of its Epistem makes progress on two diagnostic fronts Monday February 22, 2016 (MENAFN - ProactiveInvestors - UK) To get a new technology accepted is never easy but Epistem (LON:EHP) is making progress on two fronts with its Genedrive diagnostic platform. A test for Hepatitis C (HCV) has just been cleared for clinical trials by the Institut Pasteur in Paris. Epistem releases Annual Report & Accounts to 30th June 2015. View this report View company reports Could you help genedrive plc provide specialist expertise and analyses on epithelial tissue and adult stem cells to the ever-demanding biotechnology and pharmaceutical industry? If you are interested in a career with genedrive plc, contact us today with your details. Email your CV/resumé to jobs@genedrive.com genedrive plc strives to become a world class biotechnology and personalised medicine company applying its expertise to all services provided. genedrive plc aims to improve services and treatments provided by the Healthcare industry. genedrive plc is committed to ensuring accurate and timely provision of superior products and services and to continuously meet or exceed the stated or implied expectations of our customers. genedrive plc is committed to the continuous improvement of its Quality Management System and compliance with the relevant regulatory requirements. Copyright 2014-16 genedrive plc Sitemap | Privacy Policy | Terms of Use | Contact Us